|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ryan DP, Hong TS and Bardeesy N:
Pancreatic adenocarcinoma. N Engl J Med. 371:1039–1049. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gerke V, Creutz CE and Moss SE: Annexins:
Linking Ca2+ signalling to membrane dynamics. Nat Rev
Mol Cell Biol. 6:449–461. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Díaz VM, Hurtado M, Thomson TM, Reventós J
and Paciucci R: Specific interaction of tissue-type plasminogen
activator (t-PA) with annexin II on the membrane of pancreatic
cancer cells activates plasminogen and promotes invasion in vitro.
Gut. 53:993–1000. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zheng L, Foley K, Huang L, Leubner A, Mo
G, Olino K, Edil BH, Mizuma M, Sharma R, Le DT, et al: Tyrosine 23
phosphorylation-dependent cell-surface localization of annexin A2
is required for invasion and metastases of pancreatic cancer. PLoS
One. 6:e193902011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takano S, Togawa A, Yoshitomi H, Shida T,
Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Tomonaga T, et
al: Annexin II overexpression predicts rapid recurrence after
surgery in pancreatic cancer patients undergoing
gemcitabine-adjuvant chemotherapy. Ann Surg Oncol. 15:3157–3168.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kagawa S, Takano S, Yoshitomi H, Kimura F,
Satoh M, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Furukawa K, et
al: Akt/mTOR signaling pathway is crucial for gemcitabine
resistance induced by Annexin II in pancreatic cancer cells. J Surg
Res. 178:758–767. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Neesse A, Algül H, Tuveson DA and Gress
TM: Stromal biology and therapy in pancreatic cancer: A changing
paradigm. Gut. 64:1476–1484. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lowy CM and Oskarsson T: Tenascin C in
metastasis: A view from the invasive front. Cell Adh Migr.
9:112–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oskarsson T, Acharyya S, Zhang XH,
Vanharanta S, Tavazoie SF, Morris PG, Downey RJ, Manova-Todorova K,
Brogi E and Massagué J: Breast cancer cells produce tenascin C as a
metastatic niche component to colonize the lungs. Nat Med.
17:867–874. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Esposito I, Penzel R, Chaib-Harrireche M,
Barcena U, Bergmann F, Riedl S, Kayed H, Giese N, Kleeff J, Friess
H, et al: Tenascin C and annexin II expression in the process of
pancreatic carcinogenesis. J Pathol. 208:673–685. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hingorani SR, Wang L, Multani AS, Combs C,
Deramaudt TB, Hruban RH, Rustgi AK, Chang S and Tuveson DA:
Trp53R172H and KrasG12D cooperate to promote
chromosomal instability and widely metastatic pancreatic ductal
adenocarcinoma in mice. Cancer Cell. 7:469–483. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wescott MP, Rovira M, Reichert M, von
Burstin J, Means A, Leach SD and Rustgi AK: Pancreatic ductal
morphogenesis and the Pdx1 homeodomain transcription factor. Mol
Biol Cell. 20:4838–4844. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Reichert M, Takano S, Heeg S, Bakir B,
Botta GP and Rustgi AK: Isolation, culture and genetic manipulation
of mouse pancreatic ductal cells. Nat Protoc. 8:1354–1365. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takano S, Reichert M, Bakir B, Das KK,
Nishida T, Miyazaki M, Heeg S, Collins MA, Marchand B, Hicks PD, et
al: Prrx1 isoform switching regulates pancreatic cancer invasion
and metastatic colonization. Genes Dev. 30:233–247. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rovira M, Scott SG, Liss AS, Jensen J,
Thayer SP and Leach SD: Isolation and characterization of
centroacinar/terminal ductal progenitor cells in adult mouse
pancreas. Proc Natl Acad Sci USA. 107:75–80. 2010. View Article : Google Scholar
|
|
18
|
Suzuki K, Takano S, Yoshitomi H, Nishino
H, Kagawa S, Shimizu H, Furukawa K, Miyazaki M and Ohtsuka M:
Metadherin promotes metastasis by supporting putative cancer stem
cell properties and epithelial plasticity in pancreatic cancer.
Oncotarget. 8:66098–66111. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang F, Zhang L, Zhang B, Wei X, Yang Y,
Qi RZ, Ying G, Zhang N and Niu R: Anxa2 plays a critical role in
enhanced invasiveness of the multidrug resistant human breast
cancer cells. J Proteome Res. 8:5041–5047. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao P, Zhang W, Tang J, Ma XK, Dai JY, Li
Y, Jiang JL, Zhang SH and Chen ZN: Annexin II promotes invasion and
migration of human hepatocellular carcinoma cells in vitro via its
interaction with HAb18G/CD147. Cancer Sci. 101:387–395. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Beerling E, Seinstra D, de Wit E, Kester
L, van der Velden D, Maynard C, Schäfer R, van Diest P, Voest E,
van Oudenaarden A, et al: Plasticity between epithelial and
mesenchymal states unlinks EMT from metastasis-enhancing stem cell
capacity. Cell Rep. 14:2281–2288. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fischer KR, Durrans A, Lee S, Sheng J, Li
F, Wong S, Choi H, Rayes TE, Ryu S, Troeger J, et al:
Epithelial-to-mesenchymal transition is not required for lung
metastasis but contributes to chemoresistance. Nature. 527:472–476.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zheng X, Carstens JL, Kim J, Scheible M,
Kaye J, Sugimoto H, Wu CC, LeBleu VS and Kalluri R:
Epithelial-to-mesenchymal transition is dispensable for metastasis
but induces chemoresistance in pancreatic cancer. Nature.
527:525–530. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chiquet-Ehrismann R and Chiquet M:
Tenascins: Regulation and putative functions during pathological
stress. J Pathol. 200:488–499. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cai J, Du S, Wang H, Xin B, Wang J, Shen
W, Wei W, Guo Z and Shen X: Tenascin-C induces migration and
invasion through JNK/c-Jun signalling in pancreatic cancer.
Oncotarget. 8:74406–74422. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Emoto K, Yamada Y, Sawada H, Fujimoto H,
Ueno M, Takayama T, Kamada K, Naito A, Hirao S and Nakajima Y:
Annexin II overexpression correlates with stromal tenascin-C
overexpression: A prognostic marker in colorectal carcinoma.
Cancer. 92:1419–1426. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Foley K, Rucki AA, Xiao Q, Zhou D, Leubner
A, Mo G, Kleponis J, Wu AA, Sharma R, Jiang Q, et al: Semaphorin 3D
autocrine signaling mediates the metastatic role of annexin A2 in
pancreatic cancer. Sci Signal. 8:ra772015. View Article : Google Scholar : PubMed/NCBI
|
